Anal Fistula Epidemiology Forecast

DelveInsight's 'Anal Fistula - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Anal Fistula epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Anal Fistula Understanding

The DelveInsight Anal Fistula epidemiology report gives a thorough understanding of the Anal Fistula by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Anal Fistula in the US, Europe, and Japan. The report covers the detailed information of the Anal Fistula epidemiology scenario in seven major countries (US, EU5, and Japan).


Anal Fistula Epidemiology Perspective by DelveInsight

The Anal Fistula epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Anal Fistula epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Anal Fistula epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Anal Fistula Detailed Epidemiology Segmentation

The Anal Fistula epidemiology covered in the report provides historical as well as forecasted Anal Fistula epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Anal Fistula report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Anal Fistula report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Anal Fistula Epidemiology Report and Model provide an overview of the risk factors and global trends of Anal Fistula in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Anal Fistula in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Anal Fistula
  • The report provides the segmentation of the Anal Fistula epidemiology


Report Highlights

  • 11-Year Forecast of Anal Fistula epidemiology
  • 7MM Coverage
  • Total Cases of Anal Fistula
  • Total Cases of Anal Fistula according to segmentation
  • Diagnosed cases of Anal Fistula


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Anal Fistula?
  • What are the key findings pertaining to the Anal Fistula epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Anal Fistula across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Anal Fistula?
  • What are the currently available treatments of Anal Fistula?


Reasons to buy

  • The Anal Fistula Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Anal Fistula market
  • Quantify patient populations in the global Anal Fistula market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Anal Fistula therapeutics in each of the markets covered
  • Understand the magnitude of Anal Fistula population by its epidemiology
  • The Anal Fistula Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Anal Fistula

3. Anal Fistula: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Anal Fistula Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Anal Fistula Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Anal Fistula Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Anal Fistula Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Anal Fistula Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Anal Fistula Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Anal Fistula Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Anal Fistula Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Anal Fistula Treatment and Management

6.2. Anal Fistula Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Anal Fistula Epidemiology in 7MM (2017-2030)

Table 2 Anal Fistula Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Anal Fistula Epidemiology in the United States (2017-2030)

Table 4 Anal Fistula Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Anal Fistula Epidemiology in Germany (2017-2030)

Table 6 Anal Fistula Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Anal Fistula Epidemiology in France (2017-2030)

Table 8 Anal Fistula Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Anal Fistula Epidemiology in Italy (2017-2030)

Table 10 Anal Fistula Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Anal Fistula Epidemiology in Spain (2017-2030)

Table 12 Anal Fistula Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Anal Fistula Epidemiology in the United Kingdom (2017-2030)

Table 14 Anal Fistula Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Anal Fistula Epidemiology in Japan (2017-2030)

Table 16 Anal Fistula Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Anal Fistula Epidemiology in 7MM (2017-2030)

Figure 2 Anal Fistula Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Anal Fistula Epidemiology in the United States (2017-2030)

Figure 4 Anal Fistula Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Anal Fistula Epidemiology in Germany (2017-2030)

Figure 6 Anal Fistula Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Anal Fistula Epidemiology in France (2017-2030)

Figure 8 Anal Fistula Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Anal Fistula Epidemiology in Italy (2017-2030)

Figure 10 Anal Fistula Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Anal Fistula Epidemiology in Spain (2017-2030)

Figure 12 Anal Fistula Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Anal Fistula Epidemiology in the United Kingdom (2017-2030)

Figure 14 Anal Fistula Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Anal Fistula Epidemiology in Japan (2017-2030)

Figure 16 Anal Fistula Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Anal Fistula Epidemiology
  • Anal Fistula
  • Anal Fistula Pipeline
  • Anal Fistula Companies
  • Anal Fistula prevalent population
  • Anal Fistula incident population
  • Anal Fistula patients diagnosed
  • Anal Fistula treatment algorithm

Forward to Friend

Need A Quote